{
    "id": 32,
    "premise": "none",
    "hypothesis": "This treatment is not available for this patient",
    "label": "entailment",
    "explanation": "A Notch inhibitor may be effective in this patient.\nThere are no licenced Notch inhibitors available.\nThere are no Notch inhibitors in clinical trials available for hepatoblastoma patients.\nThere are no Notch inhibitors in clinical trials available for paediatric patients.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "This treatment is not available for this patient",
        "refined explanation": "A Notch inhibitor may be effective in this patient.\nThere are no licenced Notch inhibitors available.\nIf there are no licenced Notch inhibitors available, then there are no available Notch inhibitors.\nThere are no Notch inhibitors in clinical trials available for hepatoblastoma patients.\nThere are no Notch inhibitors in clinical trials available for paediatric patients.\nIf there are no available Notch inhibitors, then the treatment is not available for the patient.",
        "refined iteration": 2,
        "history explanation": [
            "0 iteration: A Notch inhibitor may be effective in this patient.\nThere are no licenced Notch inhibitors available.\nThere are no Notch inhibitors in clinical trials available for hepatoblastoma patients.\nThere are no Notch inhibitors in clinical trials available for paediatric patients.",
            "1 iteration: A Notch inhibitor may be effective in this patient.\nThere are no licenced Notch inhibitors available.\nThere are no Notch inhibitors in clinical trials available for hepatoblastoma patients.\nThere are no Notch inhibitors in clinical trials available for paediatric patients.\nIf there are no available Notch inhibitors, then the treatment is not available for the patient.",
            "2 iteration: A Notch inhibitor may be effective in this patient.\nThere are no licenced Notch inhibitors available.\nIf there are no licenced Notch inhibitors available, then there are no available Notch inhibitors.\nThere are no Notch inhibitors in clinical trials available for hepatoblastoma patients.\nThere are no Notch inhibitors in clinical trials available for paediatric patients.\nIf there are no available Notch inhibitors, then the treatment is not available for the patient."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 states that there are no licenced Notch inhibitors available. *)\\n(* Explanation 3 and 4 state that there are no Notch inhibitors in clinical trials available for specific patients. *)\\n(* We have logical relations Not(B), Not(C), and Not(D) from the explanations. *)\\n(* Since there are no available Notch inhibitors, we can infer that the treatment is not available for the patient. *)\\nthen have \"\u00acAvailableFor x y\" sledgehammer', 'solving time': 104.36342716217041, 'proof tactics': [], 'code': 'theory clinical_32_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  LicencedNotchInhibitor :: \"entity \u21d2 bool\"\\n  Available :: \"entity \u21d2 bool\"\\n  NotchInhibitorInClinicalTrial :: \"entity \u21d2 bool\"\\n  HepatoblastomaPatient :: \"entity \u21d2 bool\"\\n  AvailableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  PaediatricPatient :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: A Notch inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. NotchInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: There are no licenced Notch inhibitors available. *)\\naxiomatization where\\n  explanation_2: \"\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)\"\\n\\n(* Explanation 3: There are no Notch inhibitors in clinical trials available for hepatoblastoma patients. *)\\naxiomatization where\\n  explanation_3: \"\u00ac(\u2203x y. NotchInhibitorInClinicalTrial x \u2227 HepatoblastomaPatient y \u2227 AvailableFor x y)\"\\n\\n(* Explanation 4: There are no Notch inhibitors in clinical trials available for paediatric patients. *)\\naxiomatization where\\n  explanation_4: \"\u00ac(\u2203x y. NotchInhibitorInClinicalTrial x \u2227 PaediatricPatient y \u2227 AvailableFor x y)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Treatment x \u2227 Patient y\"\\n  (* Hypothesis: This treatment is not available for this patient. *)\\n  shows \"\u2200x y. Treatment x \u2227 Patient y \u27f6 \u00acAvailableFor x y\"\\nproof -\\n  (* From the premise, we have the known information about Treatment and Patient. *)\\n  from asm have \"Treatment x \u2227 Patient y\" <ATP>\\n  (* Explanation 2 states that there are no licenced Notch inhibitors available. *)\\n  (* Explanation 3 and 4 state that there are no Notch inhibitors in clinical trials available for specific patients. *)\\n  (* We have logical relations Not(B), Not(C), and Not(D) from the explanations. *)\\n  (* Since there are no available Notch inhibitors, we can infer that the treatment is not available for the patient. *)\\n  then have \"\u00acAvailableFor x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: a Notch inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: there are licenced Notch inhibitors available (from Explanatory Sentence 2)\\nC: there are Notch inhibitors in clinical trials available for hepatoblastoma patients (from Explanatory Sentence 3)\\nD: there are Notch inhibitors in clinical trials available for paediatric patients (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nNot(B)\\nNot(there are licenced Notch inhibitors available)\\n--------\\nNot(C)\\nNot(there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nNot(D)\\nNot(there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(C))\\nImplies(there are licenced Notch inhibitors available, Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients), Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(B, Not(D))\\nImplies(there are licenced Notch inhibitors available, Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(D, Not(B))\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(D, B)\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, there are licenced Notch inhibitors available)\\n--------\\nImplies(B, D)\\nImplies(there are licenced Notch inhibitors available, there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients), Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(C, Not(B))\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(D, Not(C))\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(C, B)\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, there are licenced Notch inhibitors available)\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(there are Notch inhibitors in clinical trials available for paediatric patients), Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(there are licenced Notch inhibitors available), Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(B, C)\\nImplies(there are licenced Notch inhibitors available, there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(there are licenced Notch inhibitors available), Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(C, D)\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\nImplies(C, Not(D))\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(there are Notch inhibitors in clinical trials available for paediatric patients), Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(D, C)\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Since there are no licenced Notch inhibitors available, we can conclude that there are no available Notch inhibitors. *)\\nhave \"\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)\" sledgehammer', 'solving time': 149.97409439086914, 'proof tactics': [], 'code': 'theory clinical_32_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  LicencedNotchInhibitor :: \"entity \u21d2 bool\"\\n  Available :: \"entity \u21d2 bool\"\\n  ClinicalTrial :: \"entity \u21d2 bool\"\\n  HepatoblastomaPatient :: \"entity \u21d2 bool\"\\n  AvailableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  PaediatricPatient :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: A Notch inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. NotchInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: There are no licenced Notch inhibitors available. *)\\naxiomatization where\\n  explanation_2: \"\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)\"\\n\\n(* Explanation 3: There are no Notch inhibitors in clinical trials available for hepatoblastoma patients. *)\\naxiomatization where\\n  explanation_3: \"\u00ac(\u2203x y. NotchInhibitor x \u2227 ClinicalTrial x \u2227 HepatoblastomaPatient y \u2227 AvailableFor x y)\"\\n\\n(* Explanation 4: There are no Notch inhibitors in clinical trials available for paediatric patients. *)\\naxiomatization where\\n  explanation_4: \"\u00ac(\u2203x y. NotchInhibitor x \u2227 ClinicalTrial x \u2227 PaediatricPatient y \u2227 AvailableFor x y)\"\\n\\n(* Explanation 5: If there are no available Notch inhibitors, then the treatment is not available for the patient. *)\\naxiomatization where\\n  explanation_5: \"(\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)) \u27f6 (\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Treatment x \u2227 Patient y\"\\n  (* Hypothesis: This treatment is not available for this patient. *)\\n  shows \"\u2200x y. Treatment x \u2227 Patient y \u27f6 \u00acAvailableFor x y\"\\nproof -\\n  (* From the explanation sentences, we know that there are no licenced Notch inhibitors available, no Notch inhibitors in clinical trials available for hepatoblastoma patients, and no Notch inhibitors in clinical trials available for paediatric patients. *)\\n  have \"\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)\" <ATP>\\n  have \"\u00ac(\u2203x y. NotchInhibitor x \u2227 ClinicalTrial x \u2227 HepatoblastomaPatient y \u2227 AvailableFor x y)\" <ATP>\\n  have \"\u00ac(\u2203x y. NotchInhibitor x \u2227 ClinicalTrial x \u2227 PaediatricPatient y \u2227 AvailableFor x y)\" <ATP>\\n  \\n  (* From explanation 5, if there are no available Notch inhibitors, then the treatment is not available for the patient. *)\\n  have \"(\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)) \u27f6 (\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z)\" <ATP>\\n  \\n  (* Since there are no licenced Notch inhibitors available, we can conclude that there are no available Notch inhibitors. *)\\n  have \"\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)\" <ATP>\\n  \\n  (* Therefore, by explanation 5, the treatment is not available for the patient. *)\\n  then have \"\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z\" <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: a Notch inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: there are licenced Notch inhibitors available (from Explanatory Sentence 2)\\nC: there are Notch inhibitors in clinical trials available for hepatoblastoma patients (from Explanatory Sentence 3)\\nD: there are Notch inhibitors in clinical trials available for paediatric patients (from Explanatory Sentence 4)\\nE: the treatment is available for the patient (from Explanatory Sentence 5)\\n\\nLogical Relations:\\nNot(B)\\nNot(there are licenced Notch inhibitors available)\\n--------\\nNot(C)\\nNot(there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nNot(D)\\nNot(there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\nImplies(Not(B) and Not(C) and Not(D), Not(E))\\nImplies(Not(there are Notch inhibitors in clinical trials available for paediatric patients), Not(the treatment is available for the patient))\\n--------\\n\\nDerived Implications:\\nImplies(C, Not(E))\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, Not(the treatment is available for the patient))\\n--------\\nImplies(D, Not(B))\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(Not(E), Not(B))\\nImplies(Not(the treatment is available for the patient), Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(D, C)\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nImplies(C, E)\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, the treatment is available for the patient)\\n--------\\nImplies(C, B)\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, there are licenced Notch inhibitors available)\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(there are licenced Notch inhibitors available), Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(the treatment is available for the patient), Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(there are Notch inhibitors in clinical trials available for paediatric patients), Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(B, Not(C))\\nImplies(there are licenced Notch inhibitors available, Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(E, Not(C))\\nImplies(the treatment is available for the patient, Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(Not(C), Not(E))\\nImplies(Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients), Not(the treatment is available for the patient))\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(there are Notch inhibitors in clinical trials available for paediatric patients), Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(B, C)\\nImplies(there are licenced Notch inhibitors available, there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nImplies(E, C)\\nImplies(the treatment is available for the patient, there are Notch inhibitors in clinical trials available for hepatoblastoma patients)\\n--------\\nImplies(E, Not(B))\\nImplies(the treatment is available for the patient, Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(Not(B), Not(E))\\nImplies(Not(there are licenced Notch inhibitors available), Not(the treatment is available for the patient))\\n--------\\nImplies(D, Not(E))\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, Not(the treatment is available for the patient))\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients), Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(B, Not(D))\\nImplies(there are licenced Notch inhibitors available, Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(E, Not(D))\\nImplies(the treatment is available for the patient, Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(D, E)\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, the treatment is available for the patient)\\n--------\\nImplies(D, B)\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, there are licenced Notch inhibitors available)\\n--------\\nImplies(B, D)\\nImplies(there are licenced Notch inhibitors available, there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients), Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(C, Not(B))\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, Not(there are licenced Notch inhibitors available))\\n--------\\nImplies(C, D)\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, there are Notch inhibitors in clinical trials available for paediatric patients)\\n--------\\nImplies(C, Not(D))\\nImplies(there are Notch inhibitors in clinical trials available for hepatoblastoma patients, Not(there are Notch inhibitors in clinical trials available for paediatric patients))\\n--------\\nImplies(D, Not(C))\\nImplies(there are Notch inhibitors in clinical trials available for paediatric patients, Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(B, Not(E))\\nImplies(there are licenced Notch inhibitors available, Not(the treatment is available for the patient))\\n--------\\nImplies(E, Not(E))\\nImplies(the treatment is available for the patient, Not(the treatment is available for the patient))\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(there are licenced Notch inhibitors available), Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(Not(E), Not(C))\\nImplies(Not(the treatment is available for the patient), Not(there are Notch inhibitors in clinical trials available for hepatoblastoma patients))\\n--------\\nImplies(E, B)\\nImplies(the treatment is available for the patient, there are licenced Notch inhibitors available)\\n--------\\nImplies(B, E)\\nImplies(there are licenced Notch inhibitors available, the treatment is available for the patient)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 8.524307250976562, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'verit found a proof...', 'vampire found a proof...', 'e found a proof...', 'cvc4 found a proof...', 'verit: Try this: using explanation_2 explanation_3 explanation_6 by blast (1 ms)', 'e: Try this: using explanation_2 explanation_3 explanation_6 by fastforce (0.6 ms)', 'zipperposition: Found duplicate proof', 'cvc4: Found duplicate proof', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'Done'], 'code': 'theory clinical_32_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  Patient :: \"entity \u21d2 bool\"\\n  EffectiveIn :: \"entity \u21d2 entity \u21d2 bool\"\\n  LicencedNotchInhibitor :: \"entity \u21d2 bool\"\\n  Available :: \"entity \u21d2 bool\"\\n  ClinicalTrial :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  AvailableFor :: \"entity \u21d2 entity \u21d2 bool\"\\n  HepatoblastomaPatients :: \"entity \u21d2 bool\"\\n  PaediatricPatients :: \"entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: A Notch inhibitor may be effective in this patient. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y. NotchInhibitor x \u2227 Patient y \u2227 EffectiveIn x y\"\\n\\n(* Explanation 2: There are no licenced Notch inhibitors available. *)\\naxiomatization where\\n  explanation_2: \"\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)\"\\n\\n(* Explanation 3: If there are no licenced Notch inhibitors available, then there are no available Notch inhibitors. *)\\naxiomatization where\\n  explanation_3: \"(\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)) \u27f6 (\u00ac(\u2203y. NotchInhibitor y \u2227 Available y))\"\\n\\n(* Explanation 4: There are no Notch inhibitors in clinical trials available for hepatoblastoma patients. *)\\naxiomatization where\\n  explanation_4: \"\u00ac(\u2203x y z. NotchInhibitor x \u2227 ClinicalTrial y \u2227 In x y \u2227 AvailableFor x z \u2227 HepatoblastomaPatients z)\"\\n\\n(* Explanation 5: There are no Notch inhibitors in clinical trials available for paediatric patients. *)\\naxiomatization where\\n  explanation_5: \"\u00ac(\u2203x y z. NotchInhibitor x \u2227 ClinicalTrial y \u2227 In x y \u2227 AvailableFor x z \u2227 PaediatricPatients z)\"\\n\\n(* Explanation 6: If there are no available Notch inhibitors, then the treatment is not available for the patient. *)\\naxiomatization where\\n  explanation_6: \"(\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)) \u27f6 (\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Treatment x \u2227 Patient y\"\\n  (* Hypothesis: This treatment is not available for this patient. *)\\n  shows \"\u2200x y. Treatment x \u2227 Patient y \u27f6 \u00acAvailableFor x y\"\\nproof -\\n  (* From the premise, we have known information about the treatment and the patient. *)\\n  from asm have \"Treatment x \u2227 Patient y\" <ATP>\\n  (* Explanation 2 states that there are no licenced Notch inhibitors available. *)\\n  from explanation_2 have \"\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)\" <ATP>\\n  (* Explanation 3 provides a logical relation: if there are no licenced Notch inhibitors available, then there are no available Notch inhibitors. *)\\n  from explanation_3 have \"(\u00ac(\u2203x. LicencedNotchInhibitor x \u2227 Available x)) \u27f6 (\u00ac(\u2203y. NotchInhibitor y \u2227 Available y))\" <ATP>\\n  (* Using Modus Ponens on explanation_2 and explanation_3, we can infer that there are no available Notch inhibitors. *)\\n  then have \"\u00ac(\u2203y. NotchInhibitor y \u2227 Available y)\" <ATP>\\n  (* Explanation 6 provides a logical relation: if there are no available Notch inhibitors, then the treatment is not available for the patient. *)\\n  from explanation_6 have \"(\u00ac(\u2203x. NotchInhibitor x \u2227 Available x)) \u27f6 (\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z)\" <ATP>\\n  (* Using Modus Ponens on the result and explanation_6, we can infer the hypothesis. *)\\n  then have \"\u2200y z. Treatment y \u2227 Patient z \u27f6 \u00acAvailableFor y z\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: A Notch inhibitor may be effective in this patient (from Explanatory Sentence 1)\\nB: There are licenced Notch inhibitors available (from Explanatory Sentence 2)\\nC: There are available Notch inhibitors (from Explanatory Sentence 3)\\nD: There are Notch inhibitors in clinical trials available for hepatoblastoma patients (from Explanatory Sentence 4)\\nE: There are Notch inhibitors in clinical trials available for paediatric patients (from Explanatory Sentence 5)\\nF: The treatment is available for the patient (from Explanatory Sentence 6)\\n\\nLogical Relations:\\nImplies(Not(B), Not(C))\\nImplies(Not(There are licenced Notch inhibitors available), Not(There are available Notch inhibitors))\\n--------\\nImplies(Not(C), Not(F))\\nImplies(Not(There are available Notch inhibitors), Not(The treatment is available for the patient))\\n--------\\n\\nDerived Implications:\\nImplies(F, B)\\nImplies(The treatment is available for the patient, There are licenced Notch inhibitors available)\\n--------\\nImplies(Not(B), Not(F))\\nImplies(Not(There are licenced Notch inhibitors available), Not(The treatment is available for the patient))\\n--------\\n'}"
        ]
    }
}